Internetové knihkupectví s veterinární tématikou
Autor:
Nakladatel | Plot |
---|---|
ISBN | 9780470932094 |
Vydání | |
Vazba | |
Počet stran |
Preface | ix |
Contributors | xi |
1 Ecotoxicity Test Methods for Endocrine-Disrupting Chemicals: An Introduction | 1 |
1.1 Background | 1 |
1.2 Regulatory Concerns | 2 |
1.3 Invertebrates | 2 |
1.4 Vertebrates | 3 |
1.5 Testing Schemes for EDCS | 5 |
Reference | 6 |
2 Endocrine Disruption in Wildlife: Background, Effects, and Implications | 7 |
2.1 Background to Endocrine Disruption | 8 |
2.2 Effects of EDCs on Wildlife | 19 |
2.3 Weight of Evidence and Ecological Significance of ED Effects | 32 |
2.4 Implications for Effect Assessment and Toxicity Testing | 36 |
2.5 Need for More Field Studies and an Integrated Approach | 38 |
2.6 Concluding Points | 39 |
References | 40 |
3 The Regulatory Need for Tests to Detect EDCs and Assess Their Hazards to Wildlife | 59 |
3.1 Emerging Concerns and Policy Responses: Focusing on EDCs as a Large Pseudo-Uniform Group of Substances | 60 |
3.2 General Approaches in Substance-Related Regulatory Frameworks (EU) | 80 |
3.3 How to Make EDC Definitions Operational for Substance-Related Regulatory Work | 87 |
3.4 Future Perspectives | 91 |
3.5 Conclusions | 92 |
References | 93 |
4 Techniques for Measuring Endocrine Disruption in Insects | 100 |
4.1 Introduction | 100 |
4.2 Methods | 105 |
4.3 Discussion | 108 |
4.4 Conclusion | 110 |
4.5 Acknowledgments | 110 |
References | 110 |
5 Crustaceans | 116 |
5.1 Introduction | 116 |
5.2 Background to Crustacean Endocrinology | 118 |
5.3 State of the Art: What Do We Know About Endocrine Disruption in Crustaceans? | 121 |
5.4 Available Subchronic/Chronic Standard Test Protocols | 128 |
5.5 Complementary Tools for Identification of Endocrine Disruption | 129 |
5.6 Summary and Conclusions | 132 |
References | 134 |
6 Endocrine Disruption in Molluscs: Processes and Testing | 143 |
6.1 Background and Introduction | 143 |
6.2 What Constitutes the Endocrine System in Molluscs? | 145 |
6.3 End Points and Biomarkers of Endocrine Disruption | 154 |
6.4 Current Test Methods Using Molluscs | 164 |
6.5 Proposed Test Methods | 167 |
6.6 Conclusions | 171 |
References | 172 |
7 Using Fish to Detect Endocrine Disrupters and Assess Their Potential Environmental Hazards | 185 |
7.1 Introduction | 185 |
7.2 International Efforts to Standardize Fish-Based Methods for Screening and Testing Endocrine-Disrupting Chemicals | 188 |
Endocrine-Disrupting Chemicals | 189 |
7.4 Progress with Developing Fish Partial Life Cycle Tests for Endocrine Disrupters | 194 |
7.5 Prospects for the Standardization of Fish Full Life Cycle and Multigeneration Tests | 195 |
7.6 Strengths and Weaknesses of a Hazard Evaluation Strategy Based Partly on Available and Proposed Fish Screens and Tests | 197 |
7.7 Conclusions | 198 |
References | 198 |
8 Screening and Testing for Endocrine-Disrupting Chemicals in Amphibian Models | 202 |
8.1 Introduction | 202 |
8.2 Potential Uses of Amphibians in Endocrine Disrupter Screening and Testing Programs | 203 |
8.3 Embryonic Development | 205 |
8.4 Hatching | 208 |
8.5 Larval Development | 209 |
8.6 Higher-Tier Tests with Amphibians | 224 |
8.7 Other and Emerging Test Methods | 227 |
8.8 Summary and Conclusions | 229 |
References | 232 |
9 Endocrine Disruption and Reptiles: Using the Unique Attributes of Temperature-Dependent Sex Determination to Assess Impacts | 245 |
9.1 Introduction | 245 |
9.2 Approaches to Examine Effects of EDCs | 252 |
9.3 Induction of Sex Reversal In Ovo | 255 |
9.4 Analysis of Sex-Reversed Animals | 260 |
9.5 Conclusions | 265 |
References | 266 |
10 Birds | 272 |
10.1 Introduction | 272 |
10.2 Differences Between Birds and Mammals and Among Bird Species | 275 |
10.3 In Vitro Techniques | 278 |
10.4 Studies with Embryos | 280 |
10.5 In Vivo Techniques | 280 |
10.6 Examples of EDC Effects from Field Studies | 285 |
10.7 Proposed Two-Generation Test | 288 |
10.8 Conclusions | 291 |
References | 292 |
11 Mammalian Methods for Detecting and Assessing Endocrine-Active Compounds | 304 |
11.1 Introduction | 304 |
11.2 Mammalian Tier 1 Screening Assays | 306 |
11.3 Tier 2 Tests | 326 |
11.4 Human and Wildlife Relevance of Estrogen, Androgen, and Thyroid Screening Assays | 329 |
11.5 Potential Future Assays for Endocrine Screening | 330 |
References | 332 |
12 Application of the OECD Conceptual Framework for Assessing the Human Health and Ecological Effects of Endocrine Disrupters | 341 |
12.1 Introduction | 342 |
12.2 Overview of the OECD Revised CF | 343 |
12.3 Application of the Klimisch Criteria to the EE2 and VIN Case Studies | 346 |
12.4 Case Study: Data Examples for 17a-Ethynylestradiol | 346 |
12.5 Case Study: Data Examples for Vinclozolin | 357 |
12.6 Conclusions | 367 |
References | 368 |
13 The Prospects for Routine Testing of Chemicals for Endocrine-Disrupting Properties and Potential Ecological Impacts | 373 |
13.1 Introduction | 373 |
13.2 Are There Gaps in the Test Suite for EDCs? | 374 |
13.3 "New" Modes of Endocrine-Disrupting Action | 376 |
13.4 How Should Tests for EDCS Be Deployed in an Integrated Fashion? | 377 |
13.5 Use of Weight of Evidence when Assessing Possible EDCS | 380 |
13.6 Conclusions | 382 |
References | 382 |
Index | 385 |